FSME-Immun Junior
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FSME-Immun Junior, covering 2015-05-21 to 2015-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children